RARA CRAFT DATABASE for FDA Medical Devices

FDA Guidance and Notices, January 2025: Draft Guidance on AI-Enabled Device Lifecycle Management and Pulse Oximeters

日本語版

January 7, 2025 brought a large batch of FDA guidance. For device regulatory teams, two drafts matter most: one on lifecycle management and marketing submissions for AI-enabled device software functions, and one on performance testing and labeling for medical pulse oximeters.

On the final side, FDA explained how it reviews PMA and HDE (Humanitarian Device Exemption) applications submitted in modules. On January 30, a safety communication warned of cybersecurity vulnerabilities in certain Contec and Epsimed patient monitors.

Final guidance

Draft guidance

In the Federal Register

Safety communications and other updates

Also this month

  • January 14: FDA held a webinar on the final guidance on Predetermined Change Control Plans (PCCPs) for AI-enabled device software functions.

Note: dates are FDA issue dates or Federal Register publication dates. Linked pages may now show a later version.

RA Craft Database is an independent service and is not affiliated with or endorsed by the U.S. FDA. Articles are for general information on product development and regulatory research; they are not legal or regulatory advice for a specific device. Official FDA documents remain the authoritative source.

← All articles